Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00152711
Status:
UNKNOWN
Last Update Posted:
2007-02-13
First Post:
2005-09-08
Brief Title:
Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis
Sponsor:
University Hospital Angers
Organization:
University Hospital Angers
Study Overview
Official Title:
Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis A Prospective Cross Over Trial
Status:
UNKNOWN
Status Verified Date:
2005-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate the impact of nasal continuous positive airway pressure nCPAP treatment on liver enzymes in patients with sleep apnea syndrome and nonalcoholic steatohepatitis Using a cross over design the evolution of liver enzymes will be evaluated in 40 patients during a consecutive period of 6 weeks with and without nCPAP treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None